Study on modulation of chemosensitivity to doxorubicin by 2-methoxyestradiol through regulation of expression of multi-drug resistance (MDR) developing genes
Samar Saad El-Deen Azab;
Abstract
Dox is one of the most valuable anticancer drugs in current clinical use. It is an integral part of the treatment of breast cancer. However, only a minority of patients with neoplastic diseases are cured. This is due to the development of tumor cell drug
Other data
| Title | Study on modulation of chemosensitivity to doxorubicin by 2-methoxyestradiol through regulation of expression of multi-drug resistance (MDR) developing genes | Authors | Samar Saad El-Deen Azab | Keywords | Study on modulation of chemosensitivity to doxorubicin by 2-methoxyestradiol through regulation of expression of multi-drug resistance (MDR) developing genes | Issue Date | 2009 | Description | Dox is one of the most valuable anticancer drugs in current clinical use. It is an integral part of the treatment of breast cancer. However, only a minority of patients with neoplastic diseases are cured. This is due to the development of tumor cell drug |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.